Cargando…
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a life-threatening complication described after administration of recombinant adenoviral vector encoding the spike protein antigen of Severe Acute Respiratory Syndrome CoronaVirus-2. The syndrome is characterized by platelet consumption an...
Autores principales: | Maraziti, Giorgio, Becattini, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603341/ https://www.ncbi.nlm.nih.gov/pubmed/34797474 http://dx.doi.org/10.1007/s11239-021-02604-2 |
Ejemplares similares
-
Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2015) -
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
por: Weingarten, Sarah J., et al.
Publicado: (2020) -
Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's
syndrome
por: Xu, Liping, et al.
Publicado: (2022) -
Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study
por: Hong, Yilei, et al.
Publicado: (2023) -
Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
por: Park, Rojin
Publicado: (2015)